Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Etilmicin derivative and preparation method thereof, pharmaceutical composition and application thereof

A technology of etimicin and derivatives is applied in the field of etimicin derivatives and preparation thereof, and achieves the effect of good resistance and significant resistance to drug-resistant bacteria

Inactive Publication Date: 2020-03-20
CHENGDU UNIV
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to solve the problems faced by the existing antibiotic production field, and provide a kind of aminoglycoside molecular derivatives and its preparation method, as well as its pharmaceutical composition and application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Etilmicin derivative and preparation method thereof, pharmaceutical composition and application thereof
  • Etilmicin derivative and preparation method thereof, pharmaceutical composition and application thereof
  • Etilmicin derivative and preparation method thereof, pharmaceutical composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Preparation of derivative A substituted with etimicin amino group (preparation scheme a)

[0041] 1. Preparation of Compound 2a

[0042] Steps: Dissolve 5.10 g of etimicin in 150 mL of methanol, add 2.14 g of DIPEA, stir at room temperature for 5 minutes, then dissolve 3.81 g of HONB-pNZ in 50 mL of THF, and add dropwise to the reaction system at room temperature; After completion, the mixture was stirred overnight at room temperature, and the solvent was evaporated under reduced pressure, followed by silica gel column chromatography to obtain compound 2a; it was a white solid with a mass of 2.84 g and a yield of 31.9%. 1 H NMR (600MHz, CDCl 3 ):δ0.99(m,1H),1.11(s,3H),1.13(t,3H),1.48(m,1H),1.69(m,2H),1.96(m,1H),2.18(d, 1H),2.42(d,1H),2.53(m,1H),2.60(s,3H),2.61(m,1H),2.71(m,1H),2.85(m,1H),2.89(m,2H ),3.11(m,2H),3.22(t,2H),3.27(t,2H),3.38(m,1H),3.42(d,1H),3.45(s,2H),3.50(m,1H) ,3.54(m,1H),3.75(m,2H),3.99(m,1H),4.89(d,2H),5.14(m,2H),5.22(m,2H),7.47(d,2H), 7.53(d,2H),8.1...

Embodiment 2

[0048] Preparation of derivatives B substituted with etimicin amino group (preparation scheme b)

[0049] Steps: Dissolve 2.31 g of etimicin in 50 mL of methanol, add 4.41 g of zinc acetate, and stir at room temperature for 10 minutes. After adding 2.04 g of acetic anhydride, the mixture was stirred overnight at room temperature. The solvent was distilled off under reduced pressure, and then separated by silica gel column chromatography to obtain Compound B with a mass of 1.79 g and a yield of 61.3%. 1 H NMR (600MHz,D 2 O): δ1.18(3H,s),1.32(m,1H),1.45(m,1H),1.66(m,3H),1.91(m,2H),1.94(m,6H),1.98(s ,3H),2.49(s,3H),2.59(d,1H),2.91(m,1H),3.19~3.30(m,4H),3.50(t,1H),3.59(t,1H),3.79( m,3H), 3.87(m,1H), 4.01(d,1H), 5.03(d,1H), 5.31(d,1H).ESIMS: Formula C 27 h 49 N 5 o 10 , found to be m / z 604.7 (M+H).

Embodiment 3

[0051] Preparation of derivative C substituted with etimicin amino group (preparation scheme c)

[0052] Steps: Dissolve 1.14 g of Compound B in 20 mL of methanol, add 1.04 g of acetic anhydride, and stir overnight at room temperature. The solvent was distilled off under reduced pressure, and then separated by silica gel column chromatography to obtain compound C with a mass of 1.10 g and a yield of 64.3%. 1 H NMR (600MHz,D 2 O): δ1.16(3H,s),1.46(m,1H),1.66(m,3H),1.89(m,1H),1.93(m,9H),1.98(s,3H),2.45(s ,3H),2.55(d,1H),3.24(m,3H),3.51(m,2H),3.66(m,2H),3.79(m,2H),3.88~3.97(m,2H),4.00( d,2H),5.02(d,1H),5.30(d,1H).ESIMS: Molecular formula C 29 h 51 N 5 o 11 , m / z 646.7 (M+H) was found.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a glycoside molecular derivative as well as a preparation method and application thereof, and belongs to the technical field of aminoglycoside antibiotics. The invention provides an etimicin derivative, and the etimicin derivative is a compound represented by the following formula and a pharmaceutically acceptable salt or prodrug thereof, wherein R1 represents a hydrogen atom, an ethyl group or an acetyl group, R2 represents a hydrogen atom, an ethyl group or an acetyl group, R3 represents a hydrogen atom, an ethyl group or an acetyl group, R4 represents a hydrogen atom,an ethyl group or an acetyl group, and R5 represents a hydrogen atom, an ethyl group or an acetyl group; wherein at least one of R1, R2, R3 is an ethyl group or an acetyl group; when R1 is an ethyl group, at least one of R2 and R3 is an ethyl group or an acetyl group; when R1 is an acetyl group, R2 and R3 can be hydrogen at the same time. The derivative can be used as a new aminoglycoside antibiotics product with low toxicity and resistance to drug-resistant bacteria, has good resistance to drug-resistant bacteria, and has a significant effect on resisting drug-resistant bacteria. The formulais shown in the description.

Description

technical field [0001] The invention relates to aminoglycoside antibiotic derivatives, in particular to a class of etimicin derivatives and a preparation method thereof, as well as a pharmaceutical composition and application thereof. Background technique [0002] Antibiotics are an effective means of treating infectious diseases. Since the 1940s, a series of aminoglycoside antibiotics, such as streptomycin, gentamicin and kanamycin, have been widely used clinically and played an important role in the field of anti-infection therapy. For some aminoglycoside antibiotics, because of their broad-spectrum antibacterial properties, rapid bactericidal effect and synergistic effect with other antibiotics such as β-lactams, they are especially suitable for the treatment of some serious infections. [0003] In recent years, along with the long-term use of antibiotics, some bacterial strains have been induced to develop drug resistance, which has led to an increasingly serious global...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07H15/236C07H1/00A61K31/7036A61P31/04
CPCC07H1/00C07H15/236
Inventor 陈仰邓盛齐刘瑜吕耷张晓游莉刘家健
Owner CHENGDU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com